We are monitoring the impact of COVID-19 on MEA Thyroid cancer Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Thyroid Cancer Market Research Report – Segmented By Treatment, End User and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2172
Pages: 140

MEA Thyroid Cancer Market Size (2022 to 2027)

The size of the Middle East and Africa Thyroid Cancer Market was USD 26.01 million in 2022. It is further expected to grow at a CAGR of 22.15% and be worth USD 70.72 million by 2027.

The growth of the MEA thyroid cancer market is anticipated to be driven by the increasing prevalence and recurrent nature of thyroid cancer and innovation and advancement in technology that ensures accurate diagnosis of thyroid cancer during the forecast period. Organizations such as the World Health Organization (WHO) and the Center for Disease Control (CDC) have stated that thyroid disorders increase rapidly and require new and effective thyroid therapies for treatment. According to a recent report, thyroid cancer ranked the third most common cancer reported in Saudi Arabia, with an incidence and mortality rate of around 10.1% and 1.4% among both sexes, respectively. From the same source, the incidence was high among females at 14.1% compared to 6% among males. Thyroid malignancy is the most common endocrine malignancy seen in the United Arab Emirates. It can be reported as the sixth most common type of cancer among the UAE population and the second among reported UAE women.

Regional government and local and international organizations focus on providing financial and medical resources to fight against different types of cancer and increase awareness. Reimbursement programs help expand the customer base and help them adhere to long-term treatment, driving the growth of the MEA thyroid cancer market. Hence, increased people awareness and developing healthcare infrastructure are having a positive impact on the market.

Target therapies have significantly benefitted from increased research and development and successful clinical trials involving specific proteins. As a result, these treatments are more effective than conventional therapies for the treatment of thyroid cancer.

However, lack of awareness, high cost of treatment, and side effects associated with the anti-cancer treatment are likely to hinder the MEA thyroid cancer market growth over the forecasted period.

This research report on the Middle East and Africa thyroid cancer market has been segmented and sub-segmented into the following categories.

By Treatment:

  • Surgery
  • Iodine Therapy
  • External Therapy
  • Thyroxine treatment
  • Chemotherapy
  • Drugs

By Drug: 

  • Levothyroxine
  • Radioiodine

By End User: 

  • Hospitals
  • Oncology Centres
  • Hospital Pharmacies
  • Retail Pharmacies

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

In 2022, the Saudi Arabian thyroid cancer market dominated the MEA market and is anticipated to continue during the forecast period. Various factors such as government emphasis on the fight against various types of cancers, reimbursement policies, technological advancements, the presence of major pharmaceutical and biotechnology companies involved in developing new therapies, and better healthcare infrastructure in this region are driving the market.

The regional market in the United Arab Emirates is the second most attractive market for thyroid cancer. This region is anticipated to be the fastest-growing market for thyroid cancer due to many patients, a growing geriatric population, and advancements in healthcare infrastructure. The overall prevalence of thyroid cancer among patients in GCC countries was recorded at 10.1%. Meanwhile, the prevalence of thyroid cancer among UAE nationals, Arabs, Asians, and Caucasians were 9.6%, 10.0%, 16.8%, and 16.3%, respectively.

Other regional markets in Kuwait, Qatar, Oman, and Africa may also witness a steady growth rate due to rapidly developing government healthcare reforms, which play a key role in raising awareness against thyroid cancer. Moreover, many factors such as the disposable income of the people of these regions, many hospitals and clinics, and thyroid cancer diagnostics centers will witness favorable growth during the forecast period.

KEY MARKET PLAYERS:

Companies holding most of the shares in the MEA Thyroid Cancer Market profiled in this report are Baxter International Inc., Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co, Abbott laboratories, Teva parenteral medicines Inc., App pharmaceuticals LLC, and Jerome Stevens Pharmaceuticals Inc.

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Treatment                                                  

                                5.1.1 Introduction                                           

                                5.1.2 Surgery                                     

                                5.1.3 Iodine Theraphy                                   

                                5.1.4 External radiotherapy                                        

                                5.1.5 Thyroxine treatment                                          

                                5.1.6  chemotherapy                                     

                                5.1.7 Drugs                                         

                                5.1.8  Y-o-Y Growth Analysis, By Treatment                                         

                                5.1.9  Market Attractiveness Analysis, By Treatment                                       

                                5.1.10 Market Share Analysis, By Treatment                                       

                5.2 End User      

                                5.2.1 Introduction                                           

                                5.2.2 Hospital                                    

                                5.2.3 Oncology centers                                 

                                5.2.4 Hospital Pharmacies                                            

                                5.2.5 Retail Pharmacies                                 

                                5.2.6 Y-o-Y Growth Analysis, By End User                                             

                                5.2.7 Market Attractiveness Analysis, By End User                                           

                                5.2.8 Market Share Analysis, By End User                                             

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Treatment                     

                                                6.1.3.3 By End User                        

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Treatment                     

                                                6.1.4.3 By End User                        

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Treatment                     

                                                6.1.5.3 By End User                        

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Baxter International Inc                                                        

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Mylan pharmaceuticals Inc                                                  

                8.3 Alara Pharmaceutical Corporation                                                    

                8.4  Bristol Myers co                                                       

                8.5  Abbott laboratories                                                               

                8.6 Teva parenteral medicines Inc                                                           

                8.7 App pharmaceuticals llc                                                         

                8.8  Jerome Stevens Pharmaceuticals Inc                                                             

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  1. Middle East & Africa Thyroid Cancer Market, By Treatment, From 2022 - 2027 (USD Million)
  2. Middle East & Africa Surgery Market, By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Iodine Theraphy Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa External radiotherapy Market, By Region, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Thyroxine treatment Market, By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa chemotherapy Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Drugs Market, By Region, From 2022 - 2027 (USD Million)
  8. Middle East & Africa Thyroid Cancer Market, By End User, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  10. Middle East & Africa Oncology Centers Market, By Region, From 2022 - 2027 (USD Million)
  11. Middle East & Africa Hospital Pharmacies Market, By Region, From 2022 - 2027 (USD Million)
  12. Middle East & Africa Retail Pharmacies Market, By Region, From 2022 - 2027 (USD Million)
  13. Middle East Thyroid Cancer Market, By Treatment, From 2022 - 2027 (USD Million)
  14. Middle East Thyroid Cancer Market, By End User, From 2022 - 2027 (USD Million)
  15. Africa Thyroid Cancer Market, By Treatment, From 2022 - 2027 (USD Million)
  16. Africa Thyroid Cancer Market, By End User, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample